Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mathé

Showing results (491-500 of 550) with videos related to

Pageof 55
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1997
Pilot study for preoperative administration of l-OHP to patients with advanced scirrhous type gastric cancerM Eriguchi, I Osada, Y Fujii, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1986
Excess of lympho-reticular cell complexes in the bone marrow linked to T cell mediated dysmyelopoiesisI Blazsek, E Goldschmidt, D Machover, et al.
Drugs Under Experimental and Clinical Research|January 1, 1986
Adriamycin, vincristine, cyclophosphamide and 5-fluorouracil (AVCF) compared with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in premenopausal breast carcinoma. Personal resultsG Mathé, J L Misset, R Plagne, et al.
Transplantation Proceedings|December 1, 1972
Bone marrow transplantation after antilymphocyte globulin conditioning--split lymphocyte chimerismG Mathé, L Schwarzenberg, J L Amiel, et al.
Cancer Treatment Reports|November 1, 1978
Pharmacologic factors and manipulation of immunity systemic adjuvants in cancer therapyG Mathé, I Florentin, L Olsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensityF Lévi, M Benavides, C Chevelle, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1991
Retinoic acid in mono- or combined differentiation therapy of myelodysplasia and acute promyelocytic leukemiaI Blazsek, C Farabos, M Musset, et al.
Anticancer Research|July 1, 1987
Mitoxantrone combined with vincristine, cyclophosphamide and fluorouracil for advanced breast cancer. A study of short-term response rateJ L Misset, R Metz, M Gil-Delgado, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|December 20, 1975
Preliminary results of an immunotherapy trial on terminal leukaemic lymphosarcomaG Mathé, D Belpomme, P Pouillart, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Preclinical and phase I studies of malonatoplatinumP Ribaud, D P Kelsen, N Alcock, et al.
Pageof 55

Showing results (491-500 of 550) with videos related to

Sort By:
Pageof 55
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1997
Pilot study for preoperative administration of l-OHP to patients with advanced scirrhous type gastric cancerM Eriguchi, I Osada, Y Fujii, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1986
Excess of lympho-reticular cell complexes in the bone marrow linked to T cell mediated dysmyelopoiesisI Blazsek, E Goldschmidt, D Machover, et al.
Drugs Under Experimental and Clinical Research|January 1, 1986
Adriamycin, vincristine, cyclophosphamide and 5-fluorouracil (AVCF) compared with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in premenopausal breast carcinoma. Personal resultsG Mathé, J L Misset, R Plagne, et al.
Transplantation Proceedings|December 1, 1972
Bone marrow transplantation after antilymphocyte globulin conditioning--split lymphocyte chimerismG Mathé, L Schwarzenberg, J L Amiel, et al.
Cancer Treatment Reports|November 1, 1978
Pharmacologic factors and manipulation of immunity systemic adjuvants in cancer therapyG Mathé, I Florentin, L Olsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensityF Lévi, M Benavides, C Chevelle, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1991
Retinoic acid in mono- or combined differentiation therapy of myelodysplasia and acute promyelocytic leukemiaI Blazsek, C Farabos, M Musset, et al.
Anticancer Research|July 1, 1987
Mitoxantrone combined with vincristine, cyclophosphamide and fluorouracil for advanced breast cancer. A study of short-term response rateJ L Misset, R Metz, M Gil-Delgado, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|December 20, 1975
Preliminary results of an immunotherapy trial on terminal leukaemic lymphosarcomaG Mathé, D Belpomme, P Pouillart, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Preclinical and phase I studies of malonatoplatinumP Ribaud, D P Kelsen, N Alcock, et al.
Pageof 55